ArticleEJNMMI research2026
Machine learning-based model for prediction of KCNJ5 mutation in unilateral primary aldosteronism based on [
Article in EJNMMI research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundKCNJ5 mutations enhance aldosterone synthase expression and are closely associated with the prognosis of unilateral primary aldosteronism (UPA). This study developed machine learning-based models with [68Ga]Ga-Pentixafor PET/CT for predicting KCNJ5 mutations in patients with UPA.
resultsMost of the clinical characteristics and all of [68Ga]Ga-Pentixafor PET/CT parameters differed significantly between the KCNJ5-MT and KCNJ5-WT patients. Among these three models based on 40 min LCR, ΔLCR, size, body mass index, creatinine, duration of hypokalemia, serum renin, age, preoperative defined daily dose, the XGBoost model had the highest predictive efficacy in the training group and the AUC was 0.915; the AUC of the AdaBoost and RF was 0.914, 0.911, respectively. The AdaBoost model had the highest predictive efficacy in the test group and the AUC was 0.866; the AUC of the XGBoost and RF was 0.844, 0.859, respectively, however, there was no significant difference in diagnostic performance between the three models. Patients with KCNJ5-MT exhibit different general clinical characteristics to those with the KCNJ5-WT, but there is little difference in the initial surgical outcome assessment.
conclusionsThis machine learning models based on [68Ga]Ga-Pentixafor PET/CT may achieve promising diagnostic efficacy for predicting KCNJ5 mutations. [68Ga]Ga-Pentixafor PET/CT parameters are the main predictors for KCNJ5 mutations, suggests its potential as a noninvasive imaging biomarker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.